OPTIMISE-CKD Drug Utilization

Clinical trial NCT05932901 · COMPLETED

Trial details

NCT number: NCT05932901
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Kidney Disease

Start date: 2022-05-04
Primary completion: 2023-09-28
Enrollment: 2682052

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.